LIPOCINE INC. Interest Receivable, Current
LIPOCINE INC. (LPCN) had Interest Receivable, Current of $101.06 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2026-08-04
- 2026-06-30: Interest Receivable, Current $101.06K.
- 2026-03-31: Interest Receivable, Current $111.41K.
- 2025-12-31: Interest Receivable, Current $14.19K.
- 2025-09-30: Interest Receivable, Current $115.27K.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $101.06K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $111.41K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $14.19K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $115.27K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $121.73K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $179.03K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $120.45K 10-K · filed 2026-03-10 |
| 2024-09-30 | $91.48K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $63.64K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $100.13K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $52.25K 10-K · filed 2025-03-13 |
| 2023-09-30 | $41.06K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $24.23K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $39.06K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $80.43K 10-K · filed 2024-03-07 |
| 2022-09-30 | $40.77K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $80.41K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $120.09K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $247.25K 10-K · filed 2023-03-10 |
| 2021-09-30 | $159.23K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $232.57K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $136.39K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $391.00 10-K · filed 2022-03-09 |
| 2020-09-30 | $11.22K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.92K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.21K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $16.52K 10-K · filed 2021-03-11 |
| 2019-09-30 | $10.85K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.61K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $16.37K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $38.51K 10-K · filed 2020-03-13 |
| 2018-09-30 | $29.89K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $46.69K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $47.25K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $23.07K 10-K · filed 2019-03-06 |
| 2017-09-30 | $9.26K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $13.48K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $35.95K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $38.94K 10-K · filed 2018-03-12 |
| 2016-09-30 | $115.20K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $104.90K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $159.84K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $144.54K 10-K · filed 2017-03-06 |
| 2015-09-30 | $146.84K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $99.45K 10-Q · filed 2015-08-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |